Alzex Neuropharma Inc. (TRRI)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
At close: Feb 6, 2026
Alzex Neuropharma Company Description
Alzex Neuropharma Inc., a development stage biopharmaceutical company, engages in developing therapeutics for the treatment of Alzheimer's Disease and other neurological diseases.
The company was formerly known as Trinity Resources Inc. and changed its name to Alzex Neuropharma Inc. in December 2022.
The company was incorporated in 1971 and is headquartered in Las Vegas, Nevada.
Alzex Neuropharma Inc.
| Country | United States |
| Founded | 1971 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 11 |
| CEO | Robert Rosner |
Contact Details
Address: 8275 S. Eastern Avenue Las Vegas, Nevada 89123 United States | |
| Phone | 310 435 0435 |
| Website | trinresinc.com |
Stock Details
| Ticker Symbol | TRRI |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US89656L1035 |
| SIC Code | 1044 |
Key Executives
| Name | Position |
|---|---|
| Robert Rosner | Chief Executive Officer, President and Director |